Penumbra, Inc.
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thromb…
Medical - Devices
US, Alameda [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | 39.10 | 429.41 | 308.71 | |
| Graham Fair Price | -54.59 | 14.10 | 31.05 | |
| PEG | 2479.04 | -2.39 | 0.09 | |
| Price/Book | -15.15 | 6.99 | 8.24 | |
| Price/Cash Flow | -12.99 | 259.21 | 297.91 | |
| Prices/Earnings | 326.88 | 191.26 | 44.80 | |
| Price/Sales | -11.51 | 30.20 | 34.13 | |
| Price/FCF | -12.99 | 259.21 | 297.91 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Bad
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | -2.39 | 0.64 | 0.66 | |
| Operating Margin | -64.71 | 0.04 | 0.12 | |
| ROA | -80.01 | < 0.005 | 0.03 | |
| ROE | 0.05 | < 0.005 | -80.12 | |
| ROIC | 0.04 | < 0.005 | -81.99 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | -0.01 | 0.02 | -48.84 | |
| Dividends QOQ | 0.00 | 0.00 | 0.00 | |
| EBIT QOQ | 1.77 | -0.65 | -63.12 | |
| EPS QOQ | 4.83 | -0.80 | -83.45 | |
| FCF QOQ | 0.19 | < 0.005 | -97.60 | |
| Revenue QOQ | 0.05 | -0.02 | -58.25 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Weak
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 357.49 | 358.52 | 0.29 | |
| Days Sales Outstanding (DSO) | 63.79 | 62.01 | -2.79 | |
| Inventory Turnover | 0.25 | 0.25 | -0.29 | |
| Debt/Capitalization | 0.17 | 0.16 | -2.73 | |
| Quick Ratio | 3.25 | 3.31 | 1.84 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 30.52 | 31.09 | 1.85 | |
| Cash | 7.49 | 8.10 | 8.15 | |
| Capex | -0.09 | -0.15 | -59.41 | |
| Free Cash Flow | 0.84 | 0.84 | -0.67 | |
| Revenue | 7.37 | 7.20 | -2.34 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Weak
Fundamentals
Financial Health
06 - Financial Health ·
Bad